Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia

Bereket Zeleke; Zebene Mekonnen; Meskele Bireda; Melaku Yitbarek

doi:doi:10.11648/j.ajhr.20231103.12

| Peer-Reviewed

Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia

Bereket Zeleke, Zebene Mekonnen, Meskele Bireda, Melaku Yitbarek

Published in American Journal of Health Research (Volume 11, Issue 3)

Received: 30 March 2023 Accepted: 10 May 2023 Published: 25 May 2023

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background: Incautious utilization of drugs by pregnant women for therapeutic reasons may result in severe functional and structural damages in the developing fetus. The objective of this study was to determine the prevalence and associated factors of prescribed drug use among pregnant women at public health center in Gurage Zone, Southern Ethiopia. Methods: Institution based cross sectional study was conducted on pregnant women. Data was collected from patient charts and interviewing pregnant women by using standard data collection tools. The data was analyzed using SPSS version 23.0 and multinomial logistic regression model was utilized estimate association across different study variables. P-values <0.05 were considered statistically significant. Results: Of a total of 418 pregnant women, about 91.1% were prescribed with at least one medication and there were an average 2.4 numbers of drugs per a prescription. Pregnant women with comorbidity were AOR = 19.66, 95% CI (8.747-44.218), who visited the health facility once were AOR = 2.787 95% CI (1.265-6.142) and twice were AOR =2.704 (1.042-7.018), and with primigravida were AOR = 3.553 95% CI (1.644-7.680) times more likely to use prescribed drugs (except ferrous sulphate). Conclusion: Although majority of the drugs used was appropriate and safe medications according to FDA risk classification system, the prevalence of prescribed medication use during pregnancy is very high in public health center of Wolkite town. Presence of comorbidity, gravidity and time of first visits to health facilities were significantly associated with prescribed drug use during pregnancy.

Published in	American Journal of Health Research (Volume 11, Issue 3)
DOI	10.11648/j.ajhr.20231103.12
Page(s)	77-83
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2023. Published by Science Publishing Group

Keywords

Pregnancy, WHO Core Prescribing Indicators, FDA Drug Category, Determinants of Drug Use

References

[1]	Kureshee NI, Dhande PP. Awareness of Mothers and Doctors about Drug Utilization Pattern for Illnesses Encountered during Pregnancy. Journal of Clinical and Diagnostic Research. 2013; 7 (11): 2470–4.
[2]	Eldalo AS, Siraj N, Ma Y. Pregnant Women ’ s Awareness and Perception About Medicines. Latin American Journal of Pharmacy. 2016; 34 (5): 869–74.
[3]	Ahmed SS, Sultana N, Begum ML, Lima LS, Abedin F. Pregnancy Induced Hypertension and Associated Factors among Pregnant Women. Journal of Gynecology and Women’s Health. 2017; 3 (4): 001–6.
[4]	Tahniyath F, Hafeez F, Sultana H, Hussain A, Rozati R. Prescription pattern of drugs in pregnancy: A review. International research Journal of pharmacy. 2015; 6 (7): 403–6.
[5]	Bhatta T. Medical problems during pregnancy. Kathmandu University Medical Journal. 2008; 6 (22): 286–272.
[6]	Fikadu M, Kebebe D, Amelo W, Gashe F. Drug Utilization Pattern and Potential Teratogenicity Risk among Pregnant Women Visiting Antenatal Clinic : The Case of a Primary Hospital. Indian Journal of Pharmacy Practice. 2015; 8 (1): 27–33.
[7]	Wen SW, Yang T, Krewski D, Yang Q, Nimrod C, Garner P, et al. Patterns of pregnancy exposure to prescription FDA C, D and X drugs in a Canadian population. Journal of Perinatology. 2008; 324–9.
[8]	Joshi H, Patel S, Patel K, Patel V. Drug Use Pattern during Pregnancy : A Prospective Study at Tertiary Care Teaching Hospital. NHL Journal of Medical Sciences. 2012; 1 (1): 14–7.
[9]	Eze U, Oparah AC, Enato EFO. Assessment of prescription profile of pregnant women visiting antenatal clinics. Pharmacy Practice. 2007; 5 (3): 135–9.
[10]	Fontoura A, Ayres LR, Martins-nagai M, Dewulf NLS. Prevalence of medication use among low risk pregnant women : A drug utilization study. African Journal of Pharmacy and Pharmacology. 2014; 8 (36): 884–92.
[11]	Inamdar IF, Aswar NR, Sonkar VK, Doibale MK. Drug Utilization Pattern During Pregnancy. Indian Medical Gazette. 2012; (August): 305–11.
[12]	Shalini S, Ravichandran V, Bk M, Sk D, Saraswathi R. Drug Utilization Studies. International Journal of Pharmaceutical Sciences and Nanotechnology. 2010; 3 (1): 803–10.
[13]	Chanie A, Belaynew W, Gedefaw A. Determinants of prescribed drug use among pregnant women in Bahir Dar city administration, Northwest Ethiopia: a cross sectional study. BMC Pregnancy and Childbirth 2014; 14: 325-332.
[14]	Molla F, Assen A, Abrha S, Masresha B, Gashaw A. Prescription drug use during pregnancy in Southern Tigray region, North Ethiopia. BMC Pregnancy and Childbirth. 2017; 1359-8.
[15]	Tsega B, Shemsu A, Ergetie Z, Food S-. Assessment of Drug Utilization among Pregnant Women in University of Gondar Teaching Hospital, North West Ethiopia. The Global Journal of Pharmaceutical Research. 2013; 2 (1): 1434–40.
[16]	Selvaraj N, Sekar A, Gandhi R, Jayabalan N, Ganesan S, Ali M, et al. Drug utilization pattern in pregnancy at a tertiary care hospital in Puducherry : a cross sectional observational study. International Journal of Basic & Clinical Pharmacology. 2018; 7 (5): 900–5.
[17]	Komaram MD and RB. Assessment of drug utilization pattern and teratogenicity risk among pregnant women attending a tertiary care hospital, Andhara Pradesh. International journal of pharrmaceutical sciences and research. 2017; 8 (12): 5291–7.
[18]	Brum LF, Pereira P, Felicetti LL, Da Silveira RD. Prescribed and unprescribed drug use among pregnant patients attended by the unified health system in Santa Rosa (state of Rio Grande do Sul, Brazil). Cien Saude Colet. 2011; 16 (5): 2435–42.

Cite This Article

Plain Text BibTeX RIS

APA Style

Bereket Zeleke, Zebene Mekonnen, Meskele Bireda, Melaku Yitbarek. (2023). Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. American Journal of Health Research, 11(3), 77-83. https://doi.org/10.11648/j.ajhr.20231103.12

Copy | Download

ACS Style

Bereket Zeleke; Zebene Mekonnen; Meskele Bireda; Melaku Yitbarek. Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. Am. J. Health Res. 2023, 11(3), 77-83. doi: 10.11648/j.ajhr.20231103.12

Copy | Download

AMA Style

Bereket Zeleke, Zebene Mekonnen, Meskele Bireda, Melaku Yitbarek. Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. Am J Health Res. 2023;11(3):77-83. doi: 10.11648/j.ajhr.20231103.12

Copy | Download

@article{10.11648/j.ajhr.20231103.12,
  author = {Bereket Zeleke and Zebene Mekonnen and Meskele Bireda and Melaku Yitbarek},
  title = {Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia},
  journal = {American Journal of Health Research},
  volume = {11},
  number = {3},
  pages = {77-83},
  doi = {10.11648/j.ajhr.20231103.12},
  url = {https://doi.org/10.11648/j.ajhr.20231103.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20231103.12},
  abstract = {Background: Incautious utilization of drugs by pregnant women for therapeutic reasons may result in severe functional and structural damages in the developing fetus. The objective of this study was to determine the prevalence and associated factors of prescribed drug use among pregnant women at public health center in Gurage Zone, Southern Ethiopia. Methods: Institution based cross sectional study was conducted on pregnant women. Data was collected from patient charts and interviewing pregnant women by using standard data collection tools. The data was analyzed using SPSS version 23.0 and multinomial logistic regression model was utilized estimate association across different study variables. P-values Results: Of a total of 418 pregnant women, about 91.1% were prescribed with at least one medication and there were an average 2.4 numbers of drugs per a prescription. Pregnant women with comorbidity were AOR = 19.66, 95% CI (8.747-44.218), who visited the health facility once were AOR = 2.787 95% CI (1.265-6.142) and twice were AOR =2.704 (1.042-7.018), and with primigravida were AOR = 3.553 95% CI (1.644-7.680) times more likely to use prescribed drugs (except ferrous sulphate). Conclusion: Although majority of the drugs used was appropriate and safe medications according to FDA risk classification system, the prevalence of prescribed medication use during pregnancy is very high in public health center of Wolkite town. Presence of comorbidity, gravidity and time of first visits to health facilities were significantly associated with prescribed drug use during pregnancy.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia
AU  - Bereket Zeleke
AU  - Zebene Mekonnen
AU  - Meskele Bireda
AU  - Melaku Yitbarek
Y1  - 2023/05/25
PY  - 2023
N1  - https://doi.org/10.11648/j.ajhr.20231103.12
DO  - 10.11648/j.ajhr.20231103.12
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 77
EP  - 83
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20231103.12
AB  - Background: Incautious utilization of drugs by pregnant women for therapeutic reasons may result in severe functional and structural damages in the developing fetus. The objective of this study was to determine the prevalence and associated factors of prescribed drug use among pregnant women at public health center in Gurage Zone, Southern Ethiopia. Methods: Institution based cross sectional study was conducted on pregnant women. Data was collected from patient charts and interviewing pregnant women by using standard data collection tools. The data was analyzed using SPSS version 23.0 and multinomial logistic regression model was utilized estimate association across different study variables. P-values Results: Of a total of 418 pregnant women, about 91.1% were prescribed with at least one medication and there were an average 2.4 numbers of drugs per a prescription. Pregnant women with comorbidity were AOR = 19.66, 95% CI (8.747-44.218), who visited the health facility once were AOR = 2.787 95% CI (1.265-6.142) and twice were AOR =2.704 (1.042-7.018), and with primigravida were AOR = 3.553 95% CI (1.644-7.680) times more likely to use prescribed drugs (except ferrous sulphate). Conclusion: Although majority of the drugs used was appropriate and safe medications according to FDA risk classification system, the prevalence of prescribed medication use during pregnancy is very high in public health center of Wolkite town. Presence of comorbidity, gravidity and time of first visits to health facilities were significantly associated with prescribed drug use during pregnancy.
VL  - 11
IS  - 3
ER  -

Copy | Download

Author Information

Bereket Zeleke

Department of Pharmacy, College of Medicine and Health Science, Wolkite University, Wolkite City, Southern Ethiopia
Zebene Mekonnen

Department of Nursing, College of Medicine and Health Science, Wolkite University, Wolkite City, Southern Ethiopia
Meskele Bireda

Department of Internal Medicine, College of Medicine and Health Science, Wolkite University, Wolkite City, Southern Ethiopia
Melaku Yitbarek

Department of Internal Medicine, College of Medicine and Health Science, Wolkite University, Wolkite City, Southern Ethiopia

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Bereket Zeleke, Zebene Mekonnen, Meskele Bireda, Melaku Yitbarek. (2023). Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. American Journal of Health Research, 11(3), 77-83. https://doi.org/10.11648/j.ajhr.20231103.12

Copy | Download

ACS Style

Bereket Zeleke; Zebene Mekonnen; Meskele Bireda; Melaku Yitbarek. Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. Am. J. Health Res. 2023, 11(3), 77-83. doi: 10.11648/j.ajhr.20231103.12

Copy | Download

AMA Style

Bereket Zeleke, Zebene Mekonnen, Meskele Bireda, Melaku Yitbarek. Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia. Am J Health Res. 2023;11(3):77-83. doi: 10.11648/j.ajhr.20231103.12

Copy | Download

@article{10.11648/j.ajhr.20231103.12,
  author = {Bereket Zeleke and Zebene Mekonnen and Meskele Bireda and Melaku Yitbarek},
  title = {Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia},
  journal = {American Journal of Health Research},
  volume = {11},
  number = {3},
  pages = {77-83},
  doi = {10.11648/j.ajhr.20231103.12},
  url = {https://doi.org/10.11648/j.ajhr.20231103.12},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajhr.20231103.12},
  abstract = {Background: Incautious utilization of drugs by pregnant women for therapeutic reasons may result in severe functional and structural damages in the developing fetus. The objective of this study was to determine the prevalence and associated factors of prescribed drug use among pregnant women at public health center in Gurage Zone, Southern Ethiopia. Methods: Institution based cross sectional study was conducted on pregnant women. Data was collected from patient charts and interviewing pregnant women by using standard data collection tools. The data was analyzed using SPSS version 23.0 and multinomial logistic regression model was utilized estimate association across different study variables. P-values Results: Of a total of 418 pregnant women, about 91.1% were prescribed with at least one medication and there were an average 2.4 numbers of drugs per a prescription. Pregnant women with comorbidity were AOR = 19.66, 95% CI (8.747-44.218), who visited the health facility once were AOR = 2.787 95% CI (1.265-6.142) and twice were AOR =2.704 (1.042-7.018), and with primigravida were AOR = 3.553 95% CI (1.644-7.680) times more likely to use prescribed drugs (except ferrous sulphate). Conclusion: Although majority of the drugs used was appropriate and safe medications according to FDA risk classification system, the prevalence of prescribed medication use during pregnancy is very high in public health center of Wolkite town. Presence of comorbidity, gravidity and time of first visits to health facilities were significantly associated with prescribed drug use during pregnancy.},
 year = {2023}
}

Copy | Download

TY  - JOUR
T1  - Prevalence and Determinants of Prescribed Drug Use Among Pregnant Women at Public Health Center in Wolkite Town, Southern Ethiopia
AU  - Bereket Zeleke
AU  - Zebene Mekonnen
AU  - Meskele Bireda
AU  - Melaku Yitbarek
Y1  - 2023/05/25
PY  - 2023
N1  - https://doi.org/10.11648/j.ajhr.20231103.12
DO  - 10.11648/j.ajhr.20231103.12
T2  - American Journal of Health Research
JF  - American Journal of Health Research
JO  - American Journal of Health Research
SP  - 77
EP  - 83
PB  - Science Publishing Group
SN  - 2330-8796
UR  - https://doi.org/10.11648/j.ajhr.20231103.12
AB  - Background: Incautious utilization of drugs by pregnant women for therapeutic reasons may result in severe functional and structural damages in the developing fetus. The objective of this study was to determine the prevalence and associated factors of prescribed drug use among pregnant women at public health center in Gurage Zone, Southern Ethiopia. Methods: Institution based cross sectional study was conducted on pregnant women. Data was collected from patient charts and interviewing pregnant women by using standard data collection tools. The data was analyzed using SPSS version 23.0 and multinomial logistic regression model was utilized estimate association across different study variables. P-values Results: Of a total of 418 pregnant women, about 91.1% were prescribed with at least one medication and there were an average 2.4 numbers of drugs per a prescription. Pregnant women with comorbidity were AOR = 19.66, 95% CI (8.747-44.218), who visited the health facility once were AOR = 2.787 95% CI (1.265-6.142) and twice were AOR =2.704 (1.042-7.018), and with primigravida were AOR = 3.553 95% CI (1.644-7.680) times more likely to use prescribed drugs (except ferrous sulphate). Conclusion: Although majority of the drugs used was appropriate and safe medications according to FDA risk classification system, the prevalence of prescribed medication use during pregnancy is very high in public health center of Wolkite town. Presence of comorbidity, gravidity and time of first visits to health facilities were significantly associated with prescribed drug use during pregnancy.
VL  - 11
IS  - 3
ER  -

Copy | Download